RS

Ravi Singh

Active Director Director DIN 08305969
DIN 08305969 First appointment Dec 2018 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2018
Shareholding value •••• Premium profile

About Ravi Singh

Data last updated:

Ravi Singh is a Director at Noviford Health Care Private Limited (since 2018). The company operates in Trading. Noviford Health Care Private Limited reported revenue of ₹15.9 Lakh (FY 2025).

DIN 08305969
Primary Designation Director
Industry Trading
First Appointment 17 Dec 2018
Oldest Company Age 7 yrs
Largest company Noviford Health Care Private Limited · ₹15.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Noviford Health Care Private Limited U51909UP2018PTC111332
Director17 Dec 20182018₹15.9 Lakh (FY 2025)Active

Board colleagues of Ravi Singh

Directorship timeline

Open interactive timeline →
Noviford Health Care Private Limited
Premium access

Shareholding and investment profile for Ravi Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Singh

Ravi Singh currently holds 1 directorship: Noviford Health Care Private Limited (Director, since 17 Dec 2018, revenue ₹15.9 Lakh (FY 2025)).

Ravi Singh was first appointed on 17 Dec 2018 as Director at Noviford Health Care Private Limited.

The current boards of Ravi Singh's companies include Raj Bahadur Singh (Noviford Health Care Private Limited), Rinki Tiwari (Noviford Health Care Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available